Werner Poewe offers a behind-the-scenes look at the development of the groundbreaking algorithm for prodromal PD risk — and recalls how he and a skeptical colleague put it to the test. https://loom.ly/12WSeYI
Werner Poewe offers a behind-the-scenes look at the development of the groundbreaking algorithm for prodromal PD risk — and recalls how he and a skeptical colleague put it to the test. https://loom.ly/12WSeYI
https://loom.ly/vxj3wIo
https://loom.ly/vxj3wIo
Oscar Gershanik details why this 2015 paper is still the go-to in the clinic today. https://loom.ly/AtBoG0E
Oscar Gershanik details why this 2015 paper is still the go-to in the clinic today. https://loom.ly/AtBoG0E
View the scientific sessions: https://loom.ly/lLFU9S8
View the scientific sessions: https://loom.ly/lLFU9S8
Christopher Goetz recounts an important turning point in clinical guidance in movement disorders and how we can continue to reshape our approach https://loom.ly/rZ6SVVU
Christopher Goetz recounts an important turning point in clinical guidance in movement disorders and how we can continue to reshape our approach https://loom.ly/rZ6SVVU
Claudia Trenkwalder explains how MDS set the standards for scientific rigor in assessments that have elevated trials, care, and treatment globally. https://loom.ly/TkekIMI
Claudia Trenkwalder explains how MDS set the standards for scientific rigor in assessments that have elevated trials, care, and treatment globally. https://loom.ly/TkekIMI
https://loom.ly/EJBg2vU
https://loom.ly/EJBg2vU
Francisco Cardoso shares about an innovative shift in the way we evaluate therapeutic options, and how it complements everyday clinical care.
Francisco Cardoso shares about an innovative shift in the way we evaluate therapeutic options, and how it complements everyday clinical care.
Help raise awareness about these and dozens of other underrecognized disorders this #MoveDisorder Day, November 29.
Help raise awareness about these and dozens of other underrecognized disorders this #MoveDisorder Day, November 29.